Charles Schwab tests spot trading in Q2, CME expands counterfeit derivatives, CORZ will clear the treasury

According to BBX data, based on official market announcements and corporate regulatory documents, the latest developments in the compliance infrastructure of global brokerage giants and the financial strategies of mining companies are as follows:

• Charles Schwab clarifies the spot trading timetable: The Charles Schwab Corporation (NYSE: $SCHW) President and CEO Rick Wurster officially confirmed in a letter to shareholders this Monday that Charles Schwab will launch spot trading services for btc-42">Bitcoin and Ethereum in the first half of 2026. The plan will undergo a limited rollout in the second quarter (Q2), followed by a full expansion to its large customer base.

• CME derivatives compliance expansion: CME Group Inc. (NASDAQ: $CME) announced that, given the record average daily nominal trading volume of $8 billion for its crypto derivatives in March this year, the company has decided to further enhance its crypto strategy by officially launching futures contracts for Avalanche (AVAX) and Sui (SUI) on May 4, including standard and micro versions.

• Core Scientific plans to fully liquidate Bitcoin reserves: Core Scientific, Inc. (NASDAQ: $CORZ) in its latest 10-K annual and quarterly regulatory filings provided Wall Street with extremely clear guidance: during 2026, the company expects to "substantially monetize all" of its Bitcoin reserves to enhance liquidity and fund planned capital expenditures. This means the company will completely transform into a spot seller, liquidating its digital treasury to purchase the hardware needed for AI transformation.